Click on headlines below to download research

On track for 2012 growth
MedicX Fund | 26/01/2012

Last week’s IMS confirmed further investment, with acquisitions and new construction in Q1. The most recent portfolio valuation (end December 2011)…

On the acquisition trail
MedicX Fund | 19/12/2011

The current gap between the group’s cost of new debt (c 4.7%) and the net initial yield on new acquisitions (c 6.0%) creates an exceptionally attractive…